Clinical Trial Update: Innovative Therapeutic Treatments to Inhibit Perineural Invasion in Pancreatic Adenocarcinoma

View source ↗

Summary

A clinical trial is exploring innovative therapies to inhibit perineural invasion in pancreatic ductal adenocarcinoma and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Status: NOT_YET_RECRUITING